← Back to Clinical Trials
Recruiting NCT06904703

Pericapsular Nerve Group and Lumbar Erector Spinae Plane Blocks for Geriatrics Undergoing Total Hip Arthroplasty

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Pericapsular Nerve
Sponsor Tanta University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 120
Sex ALL
Min Age 75 Years
Max Age N/A
Start Date 2024-12-01
Completion 2026-11-01
Interventions
General anesthesiaBupivacaine 0.5%Bupivacaine 0.5%

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study will be conducted to evaluate the effect of pericapsular nerve group and erector spinae plane block as adjuvants to general anesthesia in geriatrics undergoing total hip arthroplasty.

Eligibility Criteria

Inclusion Criteria: * Aged \>75 years. * Both sexes. * American Society of Anesthesiologists (ASA) classification I-III. * Undergoing total hip arthroplasty under general anesthesia. Exclusion Criteria: * Patient refusal. * Body mass index (BMI) \> 30 kg/m2. * Allergy to local anesthesia drugs. * Infection at the site of intervention. * Coagulopathies. * Preexisting advanced diseases of the kidney or liver.

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE PERICAPSULAR NERVE TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}